Amarin Corp Plc (AMRN)

[iryokabu]

HDG,

The substantial, non-infringing use matters in case of contributory infringement but it is not determined based on volume/market share%

The definition of "substantial" is obscure in the court. What if 99.999% or 99,999scripts/year of GV are used for CVD, and 0.001% or 1 script/year for hypertriglyceridemia? Do you still think 0.001% or 1 script/year is substantial?